PE Deals Thoma Bravo’s Tse: LOGEX growth could help mesh European healthcare LOGEX is the first investment by Thoma Bravo’s London-based European team. Craig McGlashan - 7 March 2023 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in